Early trial tests 'Living Drug' for tough autoimmune illnesses
NCT ID NCT06733935
Summary
This early-stage study is testing a new type of cell therapy called NKX019 in people with severe autoimmune diseases like systemic sclerosis, inflammatory muscle disease, and certain types of vasculitis. The main goals are to find a safe dose and see if the treatment is tolerable. Researchers will also look for early signs that it might help control these difficult conditions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nkarta Investigational Site
RECRUITINGOrange, California, 92868, United States
Contact
-
Nkarta Investigational Site
RECRUITINGMiami, Florida, 33133, United States
Contact
-
Nkarta Investigational Site
RECRUITINGPlantation, Florida, 33317, United States
Contact
-
Nkarta Investigational Site
RECRUITINGChicago, Illinois, 60612, United States
Contact
-
Nkarta Investigational Site
RECRUITINGFairway, Kansas, 66205, United States
Contact
-
Nkarta Investigational Site
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact
-
Nkarta Investigational Site
RECRUITINGMinneapolis, Minnesota, 55455, United States
Contact
-
Nkarta Investigational Site
RECRUITINGHackensack, New Jersey, 07601, United States
Contact
-
Nkarta Investigational Site
RECRUITINGStony Brook, New York, 11794, United States
Contact
-
Nkarta Investigational Site
RECRUITINGSyracuse, New York, 13202, United States
Contact
-
Nkarta Investigational Site
RECRUITINGDallas, Texas, 75201, United States
Contact
-
Nkarta Investigational Site
RECRUITINGHouston, Texas, 77002, United States
Contact
-
Nkarta Investigational Site
RECRUITINGManatí, 00674, Puerto Rico
Contact
Conditions
Explore the condition pages connected to this study.